De Burlo Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $812K | Sell |
11,626
-1,016
| -8% | -$71K | 0.11% | 59 |
|
|
2025
Q1 | $929K | Sell |
12,642
-399
| -3% | -$29.3K | 0.14% | 56 |
|
|
2024
Q4 | $854K | Sell |
13,041
-636
| -5% | -$41.7K | 0.11% | 56 |
|
|
2024
Q3 | $1.07M | Sell |
13,677
-1,029
| -7% | -$80.2K | 0.13% | 55 |
|
|
2024
Q2 | $1.15M | Hold |
14,706
| – | – | 0.15% | 52 |
|
|
2024
Q1 | $996K | Sell |
14,706
-1,586
| -10% | -$107K | 0.13% | 55 |
|
|
2023
Q4 | $1.1M | Hold |
16,292
| – | – | 0.19% | 53 |
|
|
2023
Q3 | $1.1M | Hold |
16,292
| – | – | 0.19% | 53 |
|
|
2023
Q2 | $1.17M | Hold |
16,292
| – | – | 0.19% | 61 |
|
|
2023
Q1 | $1.13M | Hold |
16,292
| – | – | 0.22% | 63 |
|
|
2022
Q4 | $1.1M | Hold |
16,292
| – | – | 0.25% | 55 |
|
|
2022
Q3 | $893K | Buy |
+16,292
| New | +$893K | 0.21% | 56 |
|
|
2022
Q2 | – | Sell |
-16,763
| Closed | -$1.11M | – | 97 |
|
|
2022
Q1 | $1.11M | Hold |
16,763
| – | – | 0.21% | 58 |
|
|
2021
Q4 | $976K | Buy |
16,763
+445
| +3% | +$25.9K | 0.14% | 72 |
|
|
2021
Q3 | $980K | Buy |
+16,318
| New | +$980K | 0.16% | 70 |
|